FDA Clears VNS Device for Paroxysmal Hemicrania, Hemicrania Continua
Patients treated with gammaCore experienced clinically meaningful benefits.
Diagnosis & Disease Information
Meloxicam/Rizatriptan Combo Under Review for Migraine Treatment
The application is supported by data from the phase 3 MOMENTUM and INTERCEPT trials.
High-Quality Diet Tied to Lower Migraine Frequency, Severity
Adherence to either DASH or Mediterranean dietary patterns tied to better migraine outcomes
MPR Weekly Dose Podcast Episode 92
This week we have news on pediatric influenza vaccine guidance; Moderna submit data for their COVID-19 booster dose; There’s new FDA warnings for some JAK inhibitors; Trudhesa nasal spray is approved; And the FDA places a clinical hold on a gene therapy for phenylketonuria.
Trudhesa Nasal Spray Approved for Acute Treatment of Migraine
The approval is supported by data from the phase 3 STOP 301 study, which evaluated the safety and tolerability of Trudhesa in 354 adults with migraine.
Neck Pain With Migraine Not Necessarily Cervical Dysfunction
Of those with migraine, some with neck pain have normal cervical musculoskeletal function, others have cervical dysfunction.
Exploring Aspirin for the Treatment and Prevention of Migraines
Aspirin has been effective for acute migraines both as a solitary modality and in combination with other drugs, and thus has clinical value in treatment and prophylaxis of the migraines overall.
Review of Acute Migraine Treatments Shows Many Effective, Opioids Not Appropriate
The aim of the study was to assess the benefits and risks associated with various acute treatments for episodic migraine.
Diet Rich in Omega 3 Fatty Acids Cuts Migraines in Adults
Diets with increased EPA, DHA with or without decrease in linoleic acid reduced headaches but did not significantly improve QOL
Study Compares Remote Electrical Neuromodulation to Migraine Meds in Adolescents
Nerivio is a wireless remote electrical neuromodulation device approved for the acute treatment of episodic or chronic migraine in patients 12 years of age and older.
